Recent News

• 07.16.2025 - Vincerx Pharma, Inc. Announces Additional Adjournment of Special Meeting - Urges Stockholders to Vote FOR Approval of Dissolution Proposal
• 07.07.2025 - Vincerx Pharma, Inc. Urges Stockholders to Vote FOR Approval of Dissolution Proposal and Announces Potential Range for Distributions to Stockholders
• 06.18.2025 - Vincerx Pharma, Inc. Announces Adjournment of Special Meeting - Will Reconvene Meeting on July 16, 2025 to Secure Votes Needed to Approve Dissolution Proposal

Recent Filings

• 07.16.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 07.07.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 07.07.2025 - 8-K Current report
• 07.07.2025 - EX-99.1 EX-99.1
• 06.18.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 06.06.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 05.15.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.15.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.12.2025 - DEF 14A Other definitive proxy statements
• 05.02.2025 - EFFECT Notice of Effectiveness